MyHealthVerse is about to create the 1st Biomarkers NFT marketplace!
Biomarkers and synthetic data will be accumulated and analyzed by means of Artificial Intelligence, followed by the minting of these data into NFTs. The NFTs minted, necessary for development in biomedical research, will eventually be uploaded to the MyHealthVerse Marketplace for sale to pharmaceutical companies and other healthcare stakeholders, by simply buying our tokens and utilizing them on the marketplace.
A non-fungible token (NFT) is a unique digital certificate registered in a blockchain to warrant and record the ownership of an asset. In short, the technology relies on a decentralized network of computers employing advanced cryptography to verify the validity of a transaction.
Biomarkers constitute points of reference for pharmaceutical companies and health institutions as fundamental tools for their research and development of drugs, vaccines etc. As we immerse ourselves more and more into the digital health era, it becomes crystal clear how crucial access to information is, let alone the potential to profit from this pool of information. When your biomarkers are minted as NFTs, this means first and foremost that you are the sole owner of this data, certifiably by NFT authentication.
A non-fungible token (NFT) is a unique digital certificate registered in a blockchain to warrant and record the ownership of an asset. In short, the technology relies on a decentralized network of computers employing advanced cryptography to verify the validity of a transaction.
Biomarkers constitute points of reference for pharmaceutical companies and health institutions as fundamental tools for their research and
development of drugs, vaccines etc. As we immerse ourselves more and more into the digital health era, it becomes crystal clear how crucial access to information is, let alone the potential to profit from this pool of information. When your biomarkers are minted as NFTs, this means first and foremost that you are the sole owner of this data, certifiably by NFT authentication.
Discovering and classifying biomarkers for numerous pathologies has been on the forefront of science and medical research for many years. Composite Biomarkers are the future of Precision and Personalized Medicine based on approaches with great prognostic and diagnostic value.
However, it has recently been established that not all human organisms and cells use the same genes or molecules in a standard and consistent way. We know that even the DNA usage of monozygotic twins can differ. Therefore, using a fixed biomarker has its limitations given that it may not apply to all and that levels of expression differ amongst us. In this direction, in an effort to surpass this drawback of “fixed biomarkers”, the establishment of “composite biomarkers” as a single personalized metric can contribute to refined clinical use.
We propose the vectorization of all multiparametric data towards scaling/staging health and disease in a unified manner.
Figure 1: Global biobanks market [3]
Global Biobanking is a thriving market, which will reach $2.69 billion by 2022 [1]. According to the latest report by Grand View Research, Inc. the global biobanks market size is expected to reach $106.9 billion by 2028. The market is expected to expand at a CAGR of 6,2% from 2021 to 2028 [2].
During the ICO, public investors will be able to purchase MyHealthVerse tokens at a competitive price compared to the exchange list price. This will elevate the project and enable public investors to benefit from holding a precious token that can be liquidated later at top price.
Based on our calculations, we need approximately 3-6 months to create both the marketplace and the token.
Dionysis Kampiotis is in the Information Technology business since 2001 as a network and systems maintenance engineer. In 2005, he created the System Control brand in Greece, specialising in IT and consulting businesses. In 2019, he created Digiboost Technologies S.R.L. in Romania, with expertise in IT, Cybersecurity and Blockchain consulting. He has been involved as an outsource advisor in many business projects including but not limited to the IT industry ever since.
Ιoannis Stamatogiannopoulos has supervised as a Project Manager the development of tools and indicators on High-Frequency Algorithmic Trading (mostly FX). He has also worked for online betting companies as a consultant on risk-management and on their KYC department. He was the President of Kalamata F.C in the 2018-2019 season. He also owns System Control S.A. and Cyberific, IT consulting companies in Greece and in Romania respectively.
Sakis Gallos started working in 2001 as a graphic designer at well-known newspapers and magazines in Greece. For the last ten years he has got involved in multiple projects as an Art Director and Creative Director as an outsource consultant. These projects have allowed him to develop a deep knowledge and understanding of how the marketing channels work.
Constantinos Tsibonis has been serving as a naval aviation officer since 1998 and has obtained certifications in personnel management and project management 2013, adult instructor training (2017) and in organizational risk management (2019), through the Hellenic Naval Academy and the Naval War School. He has also obtained a certification as an NLP Practitioner in 2020 (University of the Aegean), while he continues his studies in organizational behavior and leadership at the National and Kapodistrian University of Athens.
As a digital citizen with a background in social sciences and promoting stock market trends, Kleio seeks to interact with the public by communicating valuable information via social media platforms in an accessible manner. This means creating content and planning digital strategies to draw attention, drive traffic and ultimately build trust in an inclusive community around MyHealthVerse and NFTs Biomarkers Marketplace through data analysis and trends identification.
Flourishing in the field of graphic design since 2012, Eleni Mavropoulou has been consistently creating unique and memorable brand identities and managing their aesthetics across all media. She entered the world of web design in 2018 and her professional goals focus on neat information architecture, accessibility-ready and fully responsive UI to ensure the best UX for the end user. Eleni invests in lifelong learning in all related fields, such as digital marketing and keeps up with the latest trends in graphic and web design. She is currently in the process of obtaining certifications specialising in GDPR and social media marketing.
Dr. Leandros K. Lefakis has studied law at the universities of Athens, London and Kent, and holds a PhD in Law from the University of Athens (2003). As a member of the Athens Bar Association (appointed to the Supreme Court), his expertise is in commercial, banking, and intellectual property law and he specializes in both contentious and non-contentious matters related to patent and biotechnology law. Dr. Lefakis is the managing partner of “Dr. Leandros Lefakis Law Firm” and has served as Adjunct Professor of Law at the University of Central Greece from 2005 to 2012 and Visiting Professor for postgraduate courses at Panteion University of Athens. He has extensive experience representing and advising companies in banking, investment, and particularly in intellectual property disputes, beyond the standard areas of intellectual property such as trademarks, copyrights, patents and domain names. Dr. Lefakis provides legal opinions on complex issues and advises major pharmaceutical companies on healthcare contracts, compliance programs, and regulatory matters. He has also served as an advisor to many government organizations including but not limited to public law institutions, and Greek ministries. Dr. Lefakis is a respected author, having written books and articles on intellectual property and biotechnology law. He is actively involved in scientific collaborations and serves as a permanent editing contributor to the “Journal of Company Law”.
Nikolaos G. Manias is an experienced Chief Executive Officer with a demonstrated history of work experience in the pharmaceutical and health-care industry. As a consultant, he has collaborated with several Greek state departments to provide solutions to both long-term projects and specific problems ad hoc through the last decades, e.g. Ministry of Health (2011-2012), Ministry of Development (2009-2011; 1997-1999), Ministry of Public Order (1999-2001) and Ministry of Defense (1996-1997). Given his proficient business development insights and his sharp skillsets in data analysis and strategic marketing planning, he founded in parallel a couple of companies that propelled to his becoming a pioneering and highly esteemed professional at global bioinformatics. He is currently the founder, owner and CEO of MINTE Ltd., a company specializing in market analysis related to medicine pricing. He has also co-authored a book regarding the management and the evaluation of pharmaceutical innovation in Greece through a political economic lens of health (Kastaniotis, 2016). He speaks English, French, German, Italian and Arabic.
Asma Rafaqat is a first line healthcare professional with an experience in pharmaceutical & clinical industry as well as a content writer. As a clinical pharmacist and consultant, she has direct links with the community. She has more than 5 years experience in the industry of cryptocurrency, biotechnology and AI with a couple of companies in many countries including USA and Canada. She is a proud Pakistani currently working as a content writer and advisor.
Wasaam Ahmed is an accomplished and highly regarded professional in the field of blockchain development. With extensive expertise in EVM chains and Rust-based chains, he has garnered an exceptional reputation over the course of seven years. Demonstrating unparalleled proficiency, Wasaam excels in identifying optimal blockchain and smart contract solutions for a wide range of projects. His collaborative efforts with an exceptional team have yielded successful implementation of numerous cutting-edge marketplaces and NFT projects, including ventures within the captivating realm of the metaverse.
Complete the following form if you wish to contact us. No personal datum is shared or used by third-parties.
Subscribe to our Newsletter and stay updated with the process of creating and launching the 1st biomarkers NFT marketplace!
Email Address: info@myhealthverse.io
Location: PHARMAVERSE Ltd. Craigmuir Chambers
Road Town, Tortola, VG 1110, British Virgin Islands
